Cargando…

CXCR4 in breast cancer: oncogenic role and therapeutic targeting

Chemokines are 8–12 kDa peptides that function as chemoattractant cytokines and are involved in cell activation, differentiation, and trafficking. Chemokines bind to specific G-protein-coupled seven-span transmembrane receptors. Chemokines play a fundamental role in the regulation of a variety of ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Chao, Zhao, Hong, Chen, Haitao, Yao, Qinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560524/ https://www.ncbi.nlm.nih.gov/pubmed/26356032 http://dx.doi.org/10.2147/DDDT.S84932

Ejemplares similares

MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer
por: Arora, Ritu, et al.
Publicado: (2022)

Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis
por: Hernandez, Lorena, et al.
Publicado: (2011)

Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme
por: Chen, Yaodong, et al.
Publicado: (2019)

CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
por: Khare, Tripti, et al.
Publicado: (2021)

CCR9 in cancer: oncogenic role and therapeutic targeting
por: Tu, Zhenbo, et al.
Publicado: (2016)

CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling
por: Mir, Hina, et al.
Publicado: (2021)

Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma
por: Ito, Shigeki, et al.
Publicado: (2021)

CXCR4-Targeted Necrosis-Inducing Peptidomimetic for Treating Breast Cancer
por: Akonnor, Abraham, et al.
Publicado: (2023)

The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
por: Ling, Xiaoyang, et al.
Publicado: (2013)

The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells
por: Howard, Cory M., et al.
Publicado: (2019)

β-Catenin: oncogenic role and therapeutic target in cervical cancer
por: Wang, Bingqi, et al.
Publicado: (2020)

Essential but differential role for CXCR4 and CXCR7 in the therapeutic homingof human renal progenitor cells
por: Mazzinghi, Benedetta, et al.
Publicado: (2008)

Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
por: Eckert, Franziska, et al.
Publicado: (2018)

CXCR4 antagonists for treatment of breast cancer
por: Cortés, Javier, et al.
Publicado: (2018)

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer
por: Fejzo, Marlena S., et al.
Publicado: (2013)

The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis
por: Hawkins, Oriana E, et al.
Publicado: (2012)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020)

CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members
por: Guo, Kaibo, et al.
Publicado: (2019)

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
por: Cojoc, Monica, et al.
Publicado: (2013)

Genetic Polymorphism and Expression of CXCR4 in Breast Cancer
por: Okuyama Kishima, Marina, et al.
Publicado: (2015)

TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer
por: Cordier, Clément, et al.
Publicado: (2021)

The role of CXCR3 and its ligands in cancer
por: Wang, Xiaoming, et al.
Publicado: (2022)

Computer‐aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma
por: Yu, Xiao, et al.
Publicado: (2020)

Targeting CXCR4 in AML and ALL
por: Cancilla, Daniel, et al.
Publicado: (2020)

CXCR4-targeted theranostics in oncology
por: Buck, Andreas K., et al.
Publicado: (2022)

Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
por: Zhang, Zhigang, et al.
Publicado: (2014)

Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting
por: Mabeta, Peace
Publicado: (2018)

Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström’s Macroglobulinemia
por: Kaiser, Lisa Marie, et al.
Publicado: (2021)

Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
por: Huang, Guoyu, et al.
Publicado: (2018)

The Role of SDF-1/CXCR4/CXCR7 in Neuronal Regeneration after Cerebral Ischemia
por: Cheng, Xi, et al.
Publicado: (2017)

The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells
por: Ruffini, Pier Adelchi
Publicado: (2019)

SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance
por: Sun, Boshu, et al.
Publicado: (2022)

Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells
por: Yang, Meng, et al.
Publicado: (2019)

GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells
por: Inaguma, Shingo, et al.
Publicado: (2015)

MiR-139 Modulates Cancer Stem Cell Function of Human Breast Cancer through Targeting CXCR4
por: Cheng, Chun-Wen, et al.
Publicado: (2021)

The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets
por: Maeda, Naoyoshi, et al.
Publicado: (2017)

Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities
por: Xiong, Hanchu, et al.
Publicado: (2017)

Relationship between expression of CXCR7 and NF-κB in breast cancer tissue and occurrence of breast cancer and lymphatic metastasis
por: Yuan, Cheng-liang, et al.
Publicado: (2017)

Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
por: Cheng, Yuan, et al.
Publicado: (2021)

In Vivo Targeting of CXCR4—New Horizons
por: Schottelius, Margret, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pt920aulo09f8meau76imq6uin